iiinova — where your digital self keeps evolving

Misha Beltran

@mishabeltran.bsky.social

336 followers 102 following 0 posts

Reposted by Misha Beltran

Journal of Clinical Investigation @jci.org · 03/02/2026

Exploring the biology of metastatic hormone-sensitive prostate cancer: on the road to precision medicine In this Review, Alice Bernard-Tessier & @mishabeltran.bsky.social discuss the underlying biology in mHSPC and highlight current knowledge gaps: doi.org/10.1172/JCI2...

042

Reposted by Misha Beltran

Toni Choueiri, MD @drchoueiri.bsky.social · 07/01/2025

In Memory of Dr Felix Feng, our beloved friend and a giant in prostate cancer @ericsmall.bsky.social @ucsfcancer.bsky.social www.sciencedirect.com/science/arti...

sciencedirect.com

In Memory of Dr. Felix Feng

0249

Reposted by Misha Beltran

Eric Small MD @ericsmall.bsky.social · 19/12/2024

I'm pleased to announce that the ASCO/Conquer Cancer Foundation Felix Feng Prostate Cancer YIA is now fully endowed and will fund a young prostate cancer investigator every year, in perpetuity. The First Felix Feng YIA recipient will be announced this spring and celebrated at ASCO's annual meeting.

14711

Reposted by Misha Beltran

Toni Choueiri, MD @drchoueiri.bsky.social · 16/12/2024

SAVE THE DATE: The 4th Transatlantic Exchange in Oncology between @danafarber.bsky.social and Gustave Roussy will take place in Paris on Wednesday March 19, 2025 and will focus on Radiopharmaceuticals. Free registration and Hybrid option! In partnership with Servier and Medscape

0144

Reposted by Misha Beltran

Michael Morris, MD @mjmorrismd.bsky.social · 28/11/2024

Just in time for Thanksgiving, nice pathology framework for characterizing treatment emergent neuroendocrine #ProstateCancer, a biologically diverse entity that everyone has a hard time describing, in CCR - thanks to Michael Haffner and @mishabeltran.bsky.social aacrjournals.org/clincancerre...

aacrjournals.org

Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies

Abstract. Lineage plasticity and histologic transformation from prostate adenocarcinoma to neuroendocrine prostate cancer (NEPC) occurs in up to 15-20% of patients with castration-resistant prostate c...

0165